Literature DB >> 24445815

Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens.

Laure Guenin-Macé1, Reid Oldenburg, Fabrice Chrétien, Caroline Demangel.   

Abstract

Skin ulcers are most commonly due to circulatory or metabolic disorders and are a major public health concern. In developed countries, chronic wounds affect more than 1 % of the population and their incidence is expected to follow those observed for diabetes and obesity. In tropical and subtropical countries, an additional issue is the occurrence of ulcers of infectious origins with diverse etiologies. While the severity of cutaneous Leishmaniasis correlates with protective immune responses, Buruli ulcers caused by Mycobacterium ulcerans develop in the absence of major inflammation. Based on these two examples, this review aims to demonstrate how studies on microorganism-provoked wounds can provide insight into the molecular mechanisms controlling skin integrity. We highlight the potential interest of a mouse model of non-inflammatory skin ulceration caused by intradermal injection of mycolactone, an original lipid toxin with ulcerative and immunosuppressive properties produced by M. ulcerans.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24445815     DOI: 10.1007/s00018-014-1561-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  73 in total

1.  Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.

Authors:  Marie-Thérèse Ruf; Daniela Schütte; Aurélie Chauffour; Vincent Jarlier; Baohong Ji; Gerd Pluschke
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

Review 2.  Chronic venous disease.

Authors:  John J Bergan; Geert W Schmid-Schönbein; Philip D Coleridge Smith; Andrew N Nicolaides; Michel R Boisseau; Bo Eklof
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

3.  Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

Authors:  K M George; D Chatterjee; G Gunawardana; D Welty; J Hayman; R Lee; P L Small
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

4.  Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts.

Authors:  B Berse; J A Hunt; R J Diegel; P Morganelli; K Yeo; F Brown; R A Fava
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

5.  Steroids control paradoxical worsening of Mycobacterium ulcerans infection following initiation of antibiotic therapy.

Authors:  Janine M Trevillyan; Paul D R Johnson
Journal:  Med J Aust       Date:  2013-05-06       Impact factor: 7.738

6.  Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex.

Authors:  L M Machesky; R D Mullins; H N Higgs; D A Kaiser; L Blanchoin; R C May; M E Hall; T D Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  N-WASP regulates the epithelial junctional actin cytoskeleton through a non-canonical post-nucleation pathway.

Authors:  Eva M Kovacs; Suzie Verma; Radiya G Ali; Aparna Ratheesh; Nicholas A Hamilton; Anna Akhmanova; Alpha S Yap
Journal:  Nat Cell Biol       Date:  2011-07-24       Impact factor: 28.824

Review 8.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

9.  Evidence of oxidative stress in chronic venous ulcers.

Authors:  Tim J James; Margaret A Hughes; George W Cherry; Richard P Taylor
Journal:  Wound Repair Regen       Date:  2003 May-Jun       Impact factor: 3.617

10.  Corticosteroid use for paradoxical reactions during antibiotic treatment for Mycobacterium ulcerans.

Authors:  N Deborah Friedman; Anthony H McDonald; Michael E Robson; Daniel P O'Brien
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27
View more
  2 in total

1.  Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.

Authors:  Fatoumata Niang; Fred S Sarfo; Michael Frimpong; Laure Guenin-Macé; Mark Wansbrough-Jones; Timothy Stinear; Richard O Phillips; Caroline Demangel
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

2.  Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease.

Authors:  Richard O Phillips; Fred S Sarfo; Jordi Landier; Reid Oldenburg; Michael Frimpong; Mark Wansbrough-Jones; Kabiru Abass; William Thompson; Mark Forson; Arnaud Fontanet; Fatoumata Niang; Caroline Demangel
Journal:  PLoS Negl Trop Dis       Date:  2014-04-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.